Retinoid acid inhibits IL-1-induced iNOS, COX-2 and chemokine production in human chondrocytes

Immunological Investigations

Volumn 37, Issue 7, 2008, Pages 675-693

  Hung, Li Feng ^a   Lai, Jenn Haung ^b   Lin, Leou Chyr ^b   Wang, Shyu Jye ^b   Hou, Tsung Yun ^b   Chang, Deh Ming ^b   Liang, Chun Chin T ^a   Ho, Ling Jun ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Chemokines; Chondrocytes; Cyclooxygenase 2; Inducible nitric oxide synthase; Osteoarthritis; Retinoic acid

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CHEMOKINE; CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LUCIFERASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MONOCYTE CHEMOTACTIC PROTEIN 2; NITRIC OXIDE; NITRITE; PROSTAGLANDIN E2; RANTES; RETINOIC ACID; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CARTILAGE CELL; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DOWN REGULATION; DRUG POTENCY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPRESSION; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTHRACENES; CELL LINE; CHEMOKINES; CHONDROCYTES; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; INTERLEUKIN-1; MAP KINASE KINASE 4; NITRIC OXIDE SYNTHASE TYPE II; TRANSCRIPTION FACTOR AP-1; TRETINOIN;

EID: 52949116440     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130802307237     Document Type: Article

References (52)

1. Abulencia, J. P., Gaspard, R., Healy, Z. R., Gaarde, W. A., Quackenbush, J., Konstantopoulos, K. (2003). Shear-induced cyclooxygenase-2 via a JNK2/c-Jun-dependent pathway regulates prostaglandin receptor expression in chondrocytic cells. J.. Biol. Chem. 278:28388-28394.
2. Aida, Y., Maeno, M., Suzuki, N., Namba, A., Motohashi, M., Matsumoto, M., Makimura, M., Matsumura, H. (2006). The effect of IL-1beta on the expression of inflammatory cytokines and their receptors in human chondrocytes. Life Sci. 79: 764-771.
3. Aida, Y., Maeno, M., Suzuki, N., Shiratsuchi, H., Motohashi, M., Matsumura, H. (2005). The effect of IL-1beta on the expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human chondrocytes. Life Sci. 77:3210-3221.
4. Akimoto, H., Yamazaki, R., Hashimoto, S., Sato, T., Ito, A. (2000). 4′-Hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes. Euro. J. Pharmacol. 401:429-436.
5. Alaaeddine, N., Olee, T., Hashimoto, S., Creighton-Achermann, L., Lotz, M. (2001). Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation.[see comment]. Arthritis Rheumat. 44:1633-1643.
6. Attur, M. G., Dave, M., Cipolletta, C., Kang, P., Goldring, M. B., Patel, I. R., Abramson, S. B., Amin, A. R. (2000). Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J. Biol. Chem. 275:40307-40315.
7. Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., Barr, R. K. (2004). Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta 1697:89-101.
8. Borzi, R. M., Mazzetti, I., Cattini, L., Uguccioni, M., Baggiolini, M., Facchini, A. (2000). Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheumat. 43:1734-1741.
9. Borzi, R. M., Mazzetti, I., Macor, S., Silvestri, T., Bassi, A., Cattini, L., Facchini, A. (1999). Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett. 455:238-242.
10. Brand, C., Snaddon, J., Bailey, M., Cicuttini, F. (2001). Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study. Ann. Rheumatic Dis. 60:946-949.
11. Castor, C. W., Smith, E. M., Bignall, M. C., Hossler, P. A. (1997). Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network. J. Rheumatol. 24:2080-2089.
12. Chen, Q., Liu, S. Q., Du, Y. M., Peng, H., Sun, L. P. (2006). Carboxymethyl-chitosan protects rabbit chondrocytes from interleukin-1beta- induced apoptosis. Euro. J. Pharmacol. 541:1-8.
13. Choi, H. K. (2005). Dietary risk factors for rheumatic diseases. Curr. Opin. Rheumatol. 17:141-146.
14. Chu, C. R., Kaplan, L. D., Fu, F. H., Crossett, L. S., Studer, R. K. (2004). Recovery of articular cartilage metabolism following thermal stress is facilitated by IGF-1 and JNK inhibitor. Amer. J. Sports Med. 32:191-196.
15. Fanning, P. J., Emkey, G., Smith, R. J., Grodzinsky, A. J., Szasz, N., Trippel, S. B. (2003). Mechanical regulation of mitogen-activated protein kinase signaling in articular cartilage. J. Biol. Chem. 278:50940-50948.
16. Gaby, A. R. (1999). Alternative treatments for rheumatoid arthritis. Altern. Med. Rev. 4:392-402.
17. Gemba, T., Valbracht, J., Alsalameh, S., Lotz, M. (2002). Focal adhesion kinase and mitogen-activated protein kinases are involved in chondrocyte activation by the 29-kDa amino-terminal fibronectin fragment. J. Biol. Chem. 277:907-911.
18. Goldberg, V. M., Kresina, T. F. (1987). Immunology of articular cartilage. J. Rheumatol. 14 Spec:73-76.
19. Hashimoto, S., Takahashi, K., Amiel, D., Coutts, R. D., Lotz, M. (1998). Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheumat. 41:1266-1274.
20. Hisada, T., Adcock, I. M., Nasuhara, Y., Salmon, M., Huang, T. J., Barnes, P. J., Chung, K. F. (1999). Inhibition of ozone-induced lung neutrophilia and nuclear factor-kappaB binding activity by vitamin A in rat. Euro. J. Pharmacol. 377:63-68.
21. Ho, L. J., Lin, L. C., Hung, L. F., Wang, S. J., Lee, C. H., Chang, D. M., Lai, J. H., Tai, T. Y. (2005). Retinoic acid blocks pro-inflammatory cytokine-induced matrix metalloproteinase production by down-regulating JNK-AP-1 signaling in human chondrocytes. Biochem. Pharmacol. 70:200-208.
22. Kerin, A., Patwari, P., Kuettner, K., Cole, A., Grodzinsky, A. (2002). Molecular basis of osteoarthritis: biomechanical aspects. Cell. Mol. Life Sci. 59:27-35.
23. Lai, J. H., Ho, L. J., Lu, K. C., Chang, D. M., Shaio, M. F., Han, S. H. (2001). Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 166:6914-6924.
24. Langmann, T., Liebisch, G., Moehle, C., Schifferer, R., Dayoub, R., Heiduczek, S., Grandl, M., Dada, A., Schmitz, G. (2005). Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux. Biochim. Biophys. Acta 1740:155-161.
25. Leboy, P., Grasso-Knight, G., D'Angelo, M., Volk, S. W., Lian, J. V., Drissi, H., Stein, G. S., Adams, S. L. (2001). Smad-Runx interactions during chondrocyte maturation. J. Bone Joint Surg. Amer. 83-A Suppl 1:S15-22.
26. Lee, M. S., Ikenoue, T., Trindade, M. C., Wong, N., Goodman, S. B., Schurman, D. J., Smith, R. L. (2003). Protective effects of intermittent hydrostatic pressure on osteoarthritic chondrocytes activated by bacterial endotoxin in vitro. J. Ortho. Res. 21:117-122.
27. Liacini, A., Sylvester, J., Li, W. Q., Zafarullah, M. (2002). Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 21: 251-262.
28. Malemud, C. J. (2004). Cytokines as therapeutic targets for osteoarthritis. BioDrugs 18:23-35.
29. Mazzetti, I., Magagnoli, G., Paoletti, S., Uguccioni, M., Olivotto, E., Vitellozzi, R., Cattini, L., Facchini, A., Borzi, R. M. (2004). A role for chemokines in the induction of chondrocyte phenotype modulation. Arthritis Rheumat. 50:112-122.
30. Meulenbelt, I., Seymour, A. B., Nieuwland, M., Huizinga, T. W., van Duijn, C. M., Slagboom, P. E. (2004). Association of the interleukin-1 gene cluster with radiographic signs of osteoarthritis of the hip. Arthritis Rheumat. 50:1179-1186.
31. Murrell, G. A., Jang, D., Williams, R. J. (1995). Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 206:15-21.
32. Notoya, K., Jovanovic, D. V., Reboul, P., Martel-Pelletier, J., Mineau, F., Pelletier, J. P. (2000). The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J. Immunol. 165:3402-3410.
33. Nozaki, Y., Yamagata, T., Sugiyama, M., Ikoma, S., Kinoshita, K., Funauchi, M. (2006). Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis. Clin. Immunol. 119:272-279.
34. Pelletier, J. P., DiBattista, J. A., Roughley, P., McCollum, R., Martel-Pelletier, J. (1993). Cytokines and inflammation in cartilage degradation. Rheumat. Dis. Clin. North Amer. 19:545-568.
35. Pelletier, J. P., Fernandes, J. C., Jovanovic, D. V., Reboul, P., Martel-Pelletier, J. (2001a). Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J. Rheumatol. 28:2509-2519.
36. Pelletier, J. P., Jovanovic, D., Fernandes, J. C., Manning, P., Connor, J. R., Currie, M. G., Di Battista, J. A., Martel-Pelletier, J. (1998). Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheumat. 41:1275-1286.
37. Pelletier, J. P., Jovanovic, D. V., Lascau-Coman, V., Fernandes, J. C., Manning, P. T., Connor, J. R., Currie, M. G., Martel-Pelletier, J. (2000). Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheumat. 43:1290-1299.
38. Pelletier, J. P., Martel-Pelletier, J., Abramson, S. B. (2001b). Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. [see comment]. Arthritis Rheumat. 44:1237-1247.
39. Pujol, J. P., Loyau, G. (1987). Interleukin-1 and osteoarthritis. Life Sci. 41:1187-1198.
40. Pulsatelli, L., Dolzani, P., Piacentini, A., Silvestri, T., Ruggeri, R., Gualtieri, G., Meliconi, R., Facchini, A. (1999). Chemokine production by human chondrocytes. J. Rheumatol. 26:1992-2001.
41. 2-dependent ERK1/2 activation. J. Biol. Chem. 276: 14264-14270.
42. Reimold, A. M. (2002). TNFalpha as therapeutic target: new drugs, more applications. Curr. Drug Targets Inflam. Allergy 1:377-392.
43. Schroen, D. J., Brinckerhoff, C. E. (1996). Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun. J. Cell. Physiol. 169:320-332.
44. Singh, R., Ahmed, S., Malemud, C. J., Goldberg, V. M., Haqqi, T. M. (2003). Epigallocatechin-3-gallate selectively inhibits interleukin-1beta- induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J. Orthopaed. Res. 21:102-109.
45. Sowers, M., Lachance, L. (1999). Vitamins and arthritis. The roles of vitamins A, C, D, and E. Rheumat. Dis. Clin. N. Amer. 25:315-332.
46. Torii, A., Miyake, M., Morishita, M., Ito, K., Torii, S., Sakamoto, T. (2004). Vitamin A reduces lung granulomatous inflammation with eosinophilic and neutrophilic infiltration in Sephadex-treated rats. Euro. J. Pharmacol. 497:335-342.
47. Vaillancourt, F., Morquette, B., Shi, Q., Fahmi, H., Lavigne, P., Di Battista, J. A., Fernandes, J. C., Benderdour, M. (2007). Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade. J. Cell. Biochem. 100: 1217-1231.
48. van den Berg, W. B. (2001). Lessons from animal models of osteoarthritis. Curr. Opin. Rheumatol. 13:452-456.
49. Xu, Q., Konta, T., Furusu, A., Nakayama, K., Lucio-Cazana, J., Fine, L. G., Kitamura, M. (2002). Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J. Biol. Chem. 277:41693-41700.
50. Yang, S. P., Ho, L. J., Lin, Y. L., Cheng, S. M., Tsao, T. P., Chang, D. M., Hsu, Y. L., Shih, C. Y., Juan, T. Y., Lai, J. H. (2003). Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc. Res. 59:776-787.
51. Yuan, G. H., Masuko-Hongo, K., Sakata, M., Tsuruha, J., Onuma, H., Nakamura, H., Aoki, H., Kato, T., Nishioka, K. (2001). The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheumat. 44:1056-1070.
52. Zochling, J., March, L., Lapsley, H., Cross, M., Tribe, K., Brooks, P. (2004). Use of complementary medicines for osteoarthritis - a prospective study. Ann. Rheumat. Dis. 63:549-554.